Indication

Advanced prostatic carcinoma

Advanced prostatic carcinoma refers to a malignant epithelial neoplasm of the prostate gland that has progressed beyond localized, organ-confined disease. Read more about Advanced prostatic carcinoma

92 drugs 64 manufacturers

Advertisement

Drugs that treat it

Common Advanced prostatic carcinoma therapies.

Showing 82–90 of 92 drugs

ESTRADIOL

ESTROGENS·METASTATIC BREAST CARCINOMA·+9
PD-RX PHARM

ESTRADIOL

ESTROGENS·METASTATIC BREAST CARCINOMA·+9
AHP

ESTRADIOL

ESTROGENS·METASTATIC BREAST CARCINOMA·+9
REMEDYREPACK, I
Filter & compare in the drug finder →Opens the drug finder with Advanced prostatic carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Advanced prostatic carcinoma.

Advanced prostatic carcinoma refers to a malignant epithelial neoplasm of the prostate gland that has progressed beyond localized, organ-confined disease.

Primarily affecting older adult males, this clinical state encompasses locally advanced tumors involving regional pelvic structures or lymph nodes, as well as distant metastatic dissemination most commonly to the axial skeleton and visceral organs.

Pathophysiologically, the disease is driven by aberrant androgen receptor signaling and progressive genomic instability, leading to invasive growth, elevated serum prostate-specific antigen levels, and a clinical continuum spanning hormone-sensitive, biochemically recurrent, and castration-resistant states.

Personalize your experience

Follow Advanced prostatic carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it